Literature DB >> 17439027

Traumatic renal artery occlusion in a patient with a solitary kidney: case report of treatment with endovascular stent and review of the literature.

Jason M Dowling1, Matthew W Lube, Chadwick P Smith, Joseph Andriole.   

Abstract

Renal artery occlusion after blunt trauma is a rare occurrence, and the optimal treatment for this condition has not been established. To our knowledge, endovascular repair for blunt renal artery occlusion in a solitary kidney has not been described in the literature. This case report describes a 42-year-old woman with a solitary left kidney presenting with total occlusion of the left renal artery after a significant crush injury. She was successfully treated by percutaneous placement of an endovascular stent. Postprocedure, the patient developed acute renal failure requiring temporary dialysis. At follow-up 4 months later, the patient has normal urinary output and a normal creatinine.

Entities:  

Mesh:

Year:  2007        PMID: 17439027

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  3 in total

1.  Traumatic renal artery occlusion treated with an endovascular stent--the limitations of surgical revascularization: report of a case.

Authors:  Shigeki Kushimoto; Shin-ichiro Shiraishi; Masato Miyauchi; Seizan Tanabe; Reo Fukuda; Atsuko Tsujii; Tomohiko Masuno; Shiei Kim; Makoto Kawai; Hiroyuki Yokota; Hiroyuki Tajima
Journal:  Surg Today       Date:  2011-07-12       Impact factor: 2.549

2.  Percutaneous renal artery revascularization after prolonged ischemia secondary to blunt trauma: pooled cohort analysis.

Authors:  Younes Jahangiri; Zachary Ashwell; Khashayar Farsad
Journal:  Diagn Interv Radiol       Date:  2017 Sep-Oct       Impact factor: 2.630

3.  Renal Artery Injury Secondary to Blunt Abdominal Trauma - Two Case Reports.

Authors:  Zahoor Ahmed; Syed Nabir; Mohamed Nadeem Ahmed; Shatha Al Hilli; Vajjala Ravikumar; Umais Zaid Momin
Journal:  Pol J Radiol       Date:  2016-11-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.